Deep dive case study of antitrust claims surrounding pharmaceutical drug pricing and practices. Explore the valuation of unsecured claim in a bankruptcy setting. Address the difference between claim estimation and damage calculation. Discuss the difference between private and government insurance claims.
Identify the nature of litigation claim estimation in a bankruptcy setting
Distinguish the different payor participants for pharmaceuticals
Differentiate between claim estimation and damage calculations.